Envestnet Asset Management »

Abcellera Biologics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $80k 16k 5.03
2025-06-30 $63k 18k 3.43
2025-03-31 $49k 22k 2.23
2024-12-31 $54k 18k 2.93
2024-09-30 $60k 23k 2.60
2024-06-30 $44k 15k 2.96
2024-03-31 $64k 14k 4.53
2023-09-30 $54k 12k 4.60

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr Core Total Usd (IUSB)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Core Msci Emkt (IEMG)
Ishares Tr S&p 500 Val Etf (IVE)
NVIDIA Corporation (NVDA)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 100 Etf (OEF)

View all positions for Envestnet Asset Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Baillie Gifford & Co
Two Sigma Investments
Two Sigma Advisers
Arrowpoint Asset Management
BlackRock
Renaissance Technologies
Tang Capital Management
UBS Group
Millennium Management
Susquehanna International
Guardian Partners
Driehaus Capital Management
Citadel Advisors

View all funds holding Abcellera Biologics